BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...

Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (NasdaqGS:ACRS) from Neutral ...

Energy and Infrastructure Transition Analyst Lewis holds a virtual meeting with management on November 22 hosted by BTIG. Don't Miss out on Research Tools: Discover the latest stocks recommended by ...

Aclaris (ACRS) soared 60% Tuesday, the day after the company announced it was licensing two drug candidates, prompting ...

Jonathan Krinsky, BTIG chief market technician, joins CNBC's Closing Bell to discuss market outlooks.

BTIG Research began coverage on shares of VYNE Therapeutics (NASDAQ:VYNE – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat.com reports. The brokerage set a ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

Conservative media personality Megyn Kelly on Monday blasted “Morning Joe” hosts Joe Scarborough and Mika Brzezinski, calling ...

Plug Power (NASDAQ:PLUG) -1.1% in Thursday's trading as BTIG Research downgrades shares to Neutral from Buy, saying the company is "turning the corner but still [has] a lot of work to do." ...

BTIG analyst Gregory Lewis lowered the firm’s price target on Bloom Energy (BE) to $16 from $21 and keeps a Buy rating on the ...

BTIG is “struggling to find any good reason” for why Paysafe (PSFE) is trading down 25% today following its Q3 earnings report. The report was solid with top- and bottom-line beats and a ...

BTIG raised the firm’s price target on HealthEquity (HQY) to $130 from $110 and keeps a Buy rating on the shares. The firm is citing improving policy fundamentals, better visibility into demand trends ...